Ono Pharmaceutical Balance Sheet

Financials in millions JPY. Fiscal year is April - March.

Millions JPY. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Cash & Equivalents	237,046	204,567	166,141	96,135	69,112
Short-Term Investments	60	4,479	-	20	60
Cash & Short-Term Investments	237,106	209,046	166,141	96,155	69,172
Cash Growth	13.42%	25.82%	72.78%	39.01%	8.04%
Receivables	145,936	135,022	136,066	114,396	99,788
Inventory	57,451	74,864	48,629	44,814	41,817
Prepaid Expenses	-	20,670	14,699	10,465	10,952
Other Current Assets	27,815	15,502	48,061	79,271	59,537
Total Current Assets	468,308	455,104	413,596	345,101	281,266
Property, Plant & Equipment	101,419	105,721	104,752	108,420	112,131
Long-Term Investments	104,794	100,975	297,170	324,178	255,997
Goodwill	22,654	21,186	-	-	-
Other Intangible Assets	353,581	330,041	57,288	69,134	64,734
Long-Term Deferred Tax Assets	55,759	51,020	40,863	35,604	25,074
Other Long-Term Assets	-	-1	-1	-	1
Total Assets	1,106,515	1,064,046	913,668	882,437	739,203
Accounts Payable	62,951	89,329	60,691	66,794	49,689
Accrued Expenses	-	19,350	13,493	11,726	10,824
Short-Term Debt	35,389	-	-	-	-
Current Portion of Long-Term Debt	-	30,000	-	-	-
Current Portion of Leases	3,078	3,178	2,310	2,490	2,301
Current Income Taxes Payable	30,778	4,319	24,518	40,896	2,284
Other Current Liabilities	31,449	2,120	2,612	1,023	828
Total Current Liabilities	163,645	148,296	103,624	122,929	65,926
Long-Term Debt	75,000	105,000	-	-	-
Long-Term Leases	7,468	8,500	6,552	6,678	6,501
Pension & Post-Retirement Benefits	2,234	2,640	3,294	3,350	3,322
Long-Term Deferred Tax Liabilities	909	10,817	1,013	983	1,009
Other Long-Term Liabilities	615	591	580	684	771
Total Liabilities	249,871	275,844	115,063	134,624	77,529
Common Stock	17,358	17,358	17,358	17,358	17,358
Additional Paid-In Capital	17,378	17,458	17,458	17,080	17,241
Retained Earnings	830,086	790,908	768,183	709,890	644,754
Treasury Stock	-62,770	-63,063	-63,233	-54,161	-74,683
Comprehensive Income & Other	48,675	19,790	53,195	51,702	51,236
Total Common Equity	850,727	782,451	792,961	741,869	655,906
Minority Interest	5,917	5,751	5,644	5,944	5,768
Shareholders' Equity	856,644	788,202	798,605	747,813	661,674
Total Liabilities & Equity	1,106,515	1,064,046	913,668	882,437	739,203
Total Debt	120,935	146,678	8,862	9,168	8,802
Net Cash (Debt)	116,171	62,368	157,279	86,987	60,370
Net Cash Growth	86.27%	-60.35%	80.81%	44.09%	9.82%
Net Cash Per Share	247.12	132.76	327.64	178.12	121.58
Filing Date Shares Outstanding	469.89	469.77	469.65	488.33	488.31
Total Common Shares Outstanding	469.89	469.77	469.65	488.33	488.24
Working Capital	304,663	306,808	309,972	222,172	215,340
Book Value Per Share	1810.47	1665.59	1688.42	1519.18	1343.40
Tangible Book Value	474,492	431,224	735,673	672,735	591,172
Tangible Book Value Per Share	1009.79	917.94	1566.44	1377.61	1210.81

Source: S&P Global Market Intelligence. Standard template. Financial Sources.